We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1qx4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1qx4.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1qx4.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1qx4| PDB=1qx4 | SCENE= }}
{{STRUCTURE_1qx4| PDB=1qx4 | SCENE= }}
-
'''Structrue of S127P mutant of cytochrome b5 reductase'''
+
===Structrue of S127P mutant of cytochrome b5 reductase===
-
==Overview==
+
<!--
-
Methemoglobinemia, the first hereditary disease to be identified that involved an enzyme deficiency, has been ascribed to mutations in the enzyme cytochrome b(5) reductase. A variety of defects in either the erythrocytic or microsomal forms of the enzyme have been identified that give rise to the type I or type II variant of the disease, respectively. The positions of the methemoglobinemia-causing mutations are scattered throughout the protein sequence, but the majority of the nontruncated mutants that produce type II symptoms occur close to the flavin adenine dinucleotide (FAD) cofactor binding site. While X-ray structures have been determined for the soluble, flavin-containing diaphorase domains of the rat and pig enzymes, no X-ray or NMR structure has been described for the human enzyme or any of the methemoglobinemia variants. S127P, a mutant that causes type II methemoglobinemia, was the first to be positively identified and have its spectroscopic and kinetic properties characterized that revealed altered nicotinamide adenine dinucleotide hydride (NADH) substrate binding behavior. To understand these changes at a structural level, we have determined the structure of the S127P mutant of rat cytochrome b(5) reductase to 1.8 A resolution, providing the first structural snapshot of a cytochrome b(5) reductase mutant that causes methemoglobinemia. The high-resolution structure revealed that the adenosine diphosphate (ADP) moiety of the FAD prosthetic group is displaced into the corresponding ADP binding site of the physiological substrate, NADH, thus acting as a substrate inhibitor which is consistent with both the spectroscopic and kinetic data.
+
The line below this paragraph, {{ABSTRACT_PUBMED_14609324}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 14609324 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_14609324}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Flavin flexibility]]
[[Category: Flavin flexibility]]
[[Category: Methemoglobinemia]]
[[Category: Methemoglobinemia]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:48:15 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 17:11:18 2008''

Revision as of 14:11, 27 July 2008

Image:1qx4.png

Template:STRUCTURE 1qx4

Structrue of S127P mutant of cytochrome b5 reductase

Template:ABSTRACT PUBMED 14609324

About this Structure

1QX4 is a Single protein structure of sequence from Rattus norvegicus. Full crystallographic information is available from OCA.

Reference

The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site., Bewley MC, Davis CA, Marohnic CC, Taormina D, Barber MJ, Biochemistry. 2003 Nov 18;42(45):13145-51. PMID:14609324

Page seeded by OCA on Sun Jul 27 17:11:18 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1qx4"
Personal tools